-
Taxonomy & unit
-
us-gaap: USD and CAD
-
Description
-
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
-
Summary
-
Arbutus Biopharma Corp quarterly Liabilities, Current history and change rate from Q4 2010 to Q4 2013.
- Arbutus Biopharma Corp Liabilities, Current for the quarter ending 31 Dec 2013 was CA$12.5M, a 14.3% increase year-over-year.
Liabilities, Current, Quarterly (CAD)
Liabilities, Current, YoY Quarterly Change (%)